'Pemphigus vulgaris' diaporamas de présentation

HISTOPATHOLOGY OF IMMUNOBULLOUS DISORDERS

HISTOPATHOLOGY OF IMMUNOBULLOUS DISORDERS. DR.SHUBHA. INTRAEPIDERMAL BULLOUS DISORDERS. TARGET ANTIGENS. Located in the desmosomes the most prominent adhesion junction in stratified squamous epithelium.

1.84k views • 80 slides

Vesiculobullous diseases

948 views • 66 slides

Vesiculobullous diseases

Vesiculobullous diseases. PEMPHIGUS VULGARIS PEMPHIGUS FOLIACEUS BULLOUS PEMPHIGOID. CLASSIFICATION OF VESICULOBULLOUS DISEASES. VESICLE&BULLA

1.22k views • 41 slides

THE PATIENT WITH CHRONIC MULTIPLE LESIONS

THE PATIENT WITH CHRONIC MULTIPLE LESIONS. Patients with chronic multiple lesions are frequently misdiagnosed for weeks to months since their lesions may be confused with recurring oral mucosal disorders . The clinician can avoid

681 views • 35 slides

Pemphigus and pemphigoid

Pemphigus and pemphigoid. (pemphigus). definition ? autoimmune skin and mucous membrane vesiculobullous disease is characterized with acantholysis,bullae formation in the intraepidermal areas caused by intercellular antibodies deposited in stratum spinosum.

1.06k views • 33 slides

Pemphigus

Pemphigus. Pemphigus is a group of rare autoimmune diseases that cause blistering of the skin and mucous membranes (mouth, nose, throat, eyes, and genitals). Some forms of the disease, including the most common form, may be fatal if left untreated. Causes Pemphigus.

331 views • 10 slides

Male Organ Rash Might Be the Result of Pemphigus

150 views • 8 slides

Pemphigus Vulgaris Development Pipeline Review H1 2015

This report provides comprehensive information on the therapeutic development for Pemphigus Vulgaris, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pemphigus Vulgaris and special features on late-stage and discontinued projects.

224 views • 6 slides

Pemphigus Vulgaris Therapeutics Drugs and Companies Pipeline Review, H1 2017

Pemphigus Vulgaris Pipeline Review, H1 2017, provides in depth analysis on therapeutics under development by companies & drug profiles study based on mechanism of action (MoA), route of administration (RoA) and molecule type

106 views • 3 slides